Com os prazos iminentes estabelecidos pelos órgãos governamentais, todas as empresas farmacêuticas devem avaliar e controlar o conteúdo de nitrosaminas em seus medicamentos. As soluções geralmente têm várias camadas e podem incluir removedores de nitrito simples e seguros na formulação final do medicamento. Nesta palestra eletrônica da AAPS , os especialistas da dsm-firmenich discutem as principais considerações para a redução de nitrosaminas em medicamentos usando removedores de nitrito.
Objetivos de aprendizado:
Essa sessão tem duração de 30 minutos.
Ascorbic acid, and other nitrite scavengers, have been shown to act as functional excipients in drug products that can reduce nitrosamine formation by blocking nitrosation reactions.
Discover the latest insights on nitrosamine risk mitigation presented by dsm-firmenich during an eChalk Talk hosted by the American Association of Pharmaceutical Scientists (AAPS).
Discover how dsm-firmenich is turning insights into innovation this World Patient Safety Day, from nitrosamine risk mitigation to cannabinoid-based therapeutics.
Have an idea for a new project, a groundbreaking innovation, or a need for expert services? Let’s talk.
Don’t just take our word for it. Discover how our solutions can support your product development journey.
Customized blends of functional ingredients in one single, efficient premix.
Streamline your product development process and get to market faster.
From trade shows to conferences and other industry events, find out where you can meet us next.
Talking Nutrition, Health & Care
Explore new science, consumer insights, industry news and more in our latest articles.
Discover educational whitepapers, webinars, publications and technical information.
Request samples, place orders and view product documentation.